Evaluating a new procedure for patients with severe limb ischemia who have no other options
Official title: "Arterial-Venous Reversal Flow in "No-option" Chronic Limb-threating Ischemia (CLTI) Patients"
Run by EndoCore Lab s.r.l. · NCT06277362 · Data updated 2026-11-12
This study is testing a new procedure to see if it can help patients with severe leg circulation problems who have run out of other treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | EndoCore Lab s.r.l. Academic / other |
| Locations | 9 sites (Ancona, Ancona and 8 other locations) |
| Status | Recruiting |
| Started | January 31, 2020 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | March 24, 2026 |
| Trial ID | NCT06277362 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with non-revascularizable critical limb ischemia and active trophic lesions.
✕Probably not a fit
Patients with revascularizable critical ischemia or those unable to comply with follow-up may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the early safety and effectiveness of a novel procedure called percutaneous deep foot venous arterialization in patients with 'no-option' chronic limb-threatening ischemia (CLTI). The study will enroll patients who have previously undergone unsuccessful revascularization attempts and are at high risk for amputation. By utilizing the venous plexus of the foot as an alternative conduit for arterial flow, the study seeks to provide a potential solution for those with critical lower limb ischemia. Data will be collected on enrolled patients' demographics and medical history to evaluate outcomes.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of amputation and improve limb salvage in patients with no other treatment options.
How similar studies have gone: While this approach is innovative, existing literature indicates that similar techniques have shown promise, but this specific application is less commonly tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Patient has signed an approved informed consent form * All patients, with non-revascularizable critical lower limb ischemia defined on the basis of 2 previous unsuccessful Percutaneous Transluminal Angioplasty (PTA) attempts or on severe Medial Artery Calcification (MAC)/Small Artery Disease (SAD) stage. * Patient with Critical Limb Ischaemia, Rutherford category, 5 (minor tissue loss) or 6 (major tissue loss) with active trophic lesions * Ejection Fraction \> 30% Exclusion Criteria: * Subject no able to perform the follow up or other factors making clinical follow-up difficult * Patients with critical ischaemia of the lower limbs revascularizable by bypass or angioplasty, critical ischaemia characterised by rest pain (Rutherford class ≤ 4) * Ejection Fraction \< 30%
Where it's running
-
Irccs Inrca
Ancona, Ancona, Italy Recruiting -
Ospedale San Martino
Belluno, Italy, Italy Recruiting -
Ospedale Bufalini
Cesena, Italy, Italy Recruiting -
Ospedale Cardarelli
Naples, Italy, Italy Recruiting -
Ospedale Santa Chiara
Trento, Italy, Italy Recruiting -
Ospedale Pederzoli
Peschiera del Garda, Veneto, Italy Recruiting
Show 3 more locations
-
Ospedale di Conegliano - USLL2
Conegliano, Italy, Italy Withdrawn -
Arcispedale Santa Maria Nuova
Reggio Emilia, Italy, Italy Withdrawn -
Azienda Ospedaliera S. Maria della Misericordia
Perugia, Perugia, Italy Not yet recruiting
Study contacts
- Principal investigator: Bruno Migliara, MD — Casa di Cura Pederzoli
- Study coordinator: Gabriele Morselli, PharmD
- Email: g.morselli@endocorelab.org
- Phone: +39 3499105666
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating full-body imaging technology for skin disease detection
This study is testing a new full-body imaging technology to see if it can help doctors better detect and monitor skin diseases like skin cancer and eczema.
-
Non-invasive imaging to measure skin composition and structure
This study is testing a new non-invasive imaging technology to see if it can accurately measure different components and structures of skin in people visiting their primary care doctor, especially those at higher risk for heart issues or diabetes.
-
Early angioplasty for diabetic foot syndrome
This study is testing if getting a quick angioplasty after being diagnosed with diabetic foot ulcers helps heal the wounds better than waiting for the procedure.
-
Registry of Chronic Wounds and Ulcers
This study collects information from patients with chronic wounds and ulcers to see how well different treatments are working and to improve the quality of wound care.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
Predictors of Major Adverse Limb Events After Iliac Artery Stenting
This study tests what factors predict serious limb-related problems after iliac artery stenting in adults with peripheral artery disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.